/Investor DB

Ataraxia VC

Venture capital

San Francisco · Seed–Series A · 4 people tracked

Find your way into Ataraxia VC

Sign up to see every warm intro you have to Ataraxia VC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ataraxia VC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Early-stage investor specializing in companies that help people live longer and better, offering complementary expertise via two funds: delightful moments and the science of health and happiness.

Stage
Seed–Series A
Check
$50K – $1M
HQ
San Francisco, California, US
Leads rounds
Follows
Tracked investments
7
Acquisitions
1

Team · 4 people

from curated & public directories

What they invest in

from 5 of 7 portfolio companies

Biotech ×2Digital Health ×2Healthtech ×2Medical Devices ×2Wellness & Fitness ×2AI & Machine Learning ×1Creator Economy ×1Deep Tech ×1

HQs:United States×2

Investments · 7 tracked

founders shown can be your intro path

By year:2025 · 12021 · 12020 · 12016 · 22015 · 16 dated

Boundless Mindboundless.aiin𝕏Aug 2015

Boundless (Thrive) offers a personalized digital health app that helps users adopt small daily behavior changes across five areas — food, movement, sleep, stress management, and social connection — through baseline assessments and tailored daily guidance.

AI & Machine LearningDigital HealthHealthtechWellness & Fitness

Arianna Huffington(Founder & CEO)in

Co-investorsIVP (Institutional Venture Partners)Focal VenturesJoyance PartnersNew York Venture PartnersRevolutionSocial Starts

DermBiontdermbiont.comin

DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.

BiotechDigital HealthMedical DevicesBoston, US

Robert Brucker(Executive Officer)inKarl R. Beutner(Executive Officer, Director)inNichola Eliovits(Executive Officer, Director)inMax Dawson(Executive Officer)in

BoardWilder Ramsey(Director)inJennifer Lee(Director)

Co-investorsCivilization Ventures Management, LlcJoyance PartnersOlive Tree CapitalStart CapitalToba CapitalValia Ventures+2 more

Epicore Biosystemsepicorebiosystems.cominSeries B · May 2025 · $6M

Epicore Biosystems is a digital health company that develops wearable sweat-sensing devices measuring hydration, electrolyte loss, skin temperature, motion and other biomarkers.

BiotechCambridge, US

Roozbeh Ghaffari(CEO/Co-Founder/Board Member)inJohn Rogers(Co-Founder/Board Member)inAlexander J. Aranyosi(Executive Officer)inAJ Aranyosi, PhD(Chief Digital Officer/Co-Founder)Stephen Lee(Chief Technology Officer/Co-Founder)inJames Ryan(Executive Officer)in

Co-investorsAlumni VenturesCastor VenturesJoyance PartnersMilkbox PartnersSteele Foundation for HopePegasus Tech Ventures

Scatterscatter.nyc𝕏Nov 2016 · $1Macquired by Evercoast · Jun 2024

Scatter is the developer of Depthkit, software for volumetric filmmaking and 3D video capture.

Creator EconomyDeep TechMedia & EntertainmentNew York

Andrew Scott(Founder)in

Co-investorsEniac VenturesJoyance PartnersSocial StartsWXR FundLux CapitalMax Ventures+1 more

Sigrid Therapeuticssigridthx.comNov 2021 · $8M

Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut.

HealthtechMedical DevicesWellness & Fitness

Sana Alajmovic(Co-founder & CEO)

Co-investorsJoyance Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

OgaOriginal Stitch

Exits · 1

1 acquisitions

Scatteracq. by Evercoast

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Ataraxia VC made?
Ataraxia VC has 7 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does Ataraxia VC invest at?
Ataraxia VC invests at the Seed, Series A stages.
What is Ataraxia VC's typical check size?
Ataraxia VC typically writes checks of $50K – $1M.
What sectors does Ataraxia VC focus on?
Ataraxia VC focuses on AgTech, Biotech, Consumer, FoodTech, Healthtech, Social.
Where is Ataraxia VC located?
Ataraxia VC is headquartered in San Francisco, US.
Does Ataraxia VC lead rounds?
Ataraxia VC typically participates in rounds rather than leading them.

Similar investors

Featured in lists